Contribution of human recombinant Interferon-Alpha 2b treatment in symptomatic and asymptomatic patients with SARS-CoV-2 virus infection

• Autors principals: Cristobal Gonzáles-Losada (Autor), Anabel González-Blanco (Autor), Luis Gabriel González-Lodeiro (Autor), Abraham Ismael Beato Canfux (Autor), Diana del- (Autor), Gerardo Enrique Guillén-Nieto (Autor)
• Format: Llibre
• Publicat: Universidad de Ciencias Médicas de La Habana, 2022-10-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Introduction: Subjects with asymptomatic infections are not generally admitted to health care facilities, however, they may benefit from antiviral therapy. Objective:  To evaluate the contribution to treatment with combined therapy based on recombinant human interferon alpha 2b + Lopinavir/Ritonavir...